Delivery Order SPE2DX22D0129-SPE2D826F0CBF
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $49,771.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the company's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, valued at $42,026.88, represents a non-competitive set-aside award to the prime contractor. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child delivery order under the company's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $66,973.11 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside delivery order (Contract No. 4570204693) represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a $11,508 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, under a firm fixed-price contract with an ultimate completion date of December 9, 2025. This non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The order will be performed at the contractor's corporate office in...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,179.22 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, issued as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's broader relationship with the Defense Logistics Agency (DLA). The award is structured as a delivery order, indicating it derives from an existing indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,796.20 to AmerisourceBergen Drug Corp on December 7, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,793.06 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This competitively awarded, non-set-aside contract carries a firm fixed price structure and is scheduled for completion by December 9, 2025. The delivery order represents a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $110,752.60 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $82,747.08 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The prime contractor,...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0CBFDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, with a ceiling value of $551,900.70 under a firm fixed price contract. This non-set-aside delivery order is expected to be completed by December 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under a larger indefinite delivery vehicle, leveraging AmerisourceBergen's established relationship with the federal medical procurement system to supply critical pharmaceutical products and medical commodities to support defense and military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant prime indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the underlying vehicle for this and other delivery orders. The company's federal contract portfolio demonstrates extensive capability in supplying a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Through this delivery order and its broader prime contract relationship, AmerisourceBergen supports multiple federal healthcare systems including the Defense Health Agency and U.S. Coast Guard, positioning itself as a critical vendor in the federal medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $551.9k | 12/7/25 |